MRC/info4africa KZN Community Forum | March 2012info4africa
Miss Dhirisha Naidoo - Clinical Manager of Male Medical Circumcision Programme at McCord Hospital spoke on the primary concepts related to prevention of infectious diseases, with a focus on Male Medical Circumcision (MMC). Based on the biological plausibility and epidemiological evidence, Miss Naidoo's presentation focused on the individual and public health benefits of Medical Male Circumcision (MMC). She also outlined the comprehensive programme based at McCord Hospital, and the challenges faced by the institution.
COUNTDOWN on WHO 2020 Targets: Strengthening Health Systems Interventions for...COUNTDOWN on NTDs
This presentation was given by Professor Russell Stothard on 27th June 2019 during Nigeria's 1st International Scientific Conference on NTDs Control and Elimination in Nigeria
MRC/HIVAN KZN AIDS Forum - 30/10/12 - Challenges and Opportunities for HIV/AI...info4africa
This presentation was given on 30/10/12 at the MRC/HIVAN KZN AIDS Forum.
Co-presented by Kwazi Mbatha (CEGAA Researcher/Trainer) and Mlungisi Vila kasi (TAC Community Mobiliser - uMgungundlovu), this talk was facilitated by Judith King (CEGAA Communications and Advocacy Manager).
For more information on CEGAA please visit their website: http://www.cegaa.org/
MRC/info4africa KZN Community Forum | March 2012info4africa
Miss Dhirisha Naidoo - Clinical Manager of Male Medical Circumcision Programme at McCord Hospital spoke on the primary concepts related to prevention of infectious diseases, with a focus on Male Medical Circumcision (MMC). Based on the biological plausibility and epidemiological evidence, Miss Naidoo's presentation focused on the individual and public health benefits of Medical Male Circumcision (MMC). She also outlined the comprehensive programme based at McCord Hospital, and the challenges faced by the institution.
COUNTDOWN on WHO 2020 Targets: Strengthening Health Systems Interventions for...COUNTDOWN on NTDs
This presentation was given by Professor Russell Stothard on 27th June 2019 during Nigeria's 1st International Scientific Conference on NTDs Control and Elimination in Nigeria
MRC/HIVAN KZN AIDS Forum - 30/10/12 - Challenges and Opportunities for HIV/AI...info4africa
This presentation was given on 30/10/12 at the MRC/HIVAN KZN AIDS Forum.
Co-presented by Kwazi Mbatha (CEGAA Researcher/Trainer) and Mlungisi Vila kasi (TAC Community Mobiliser - uMgungundlovu), this talk was facilitated by Judith King (CEGAA Communications and Advocacy Manager).
For more information on CEGAA please visit their website: http://www.cegaa.org/
Survillance and notification of communicable diseasemubeenButt5
Ongoing, systematic collection, analysis and interpretation of health data.
Surveillance and notification of communicable disease
1-Closely integrated with the timely dissemination to those who need to know.
Application of the data to preventing and controlling disease.
2-Authoritative or urgent, formal or legal notice.
The action of notifying someone or something.
Something that gives official information to someone : the act of notifying someone.
3-Monitor closely to all patients.
Collect patient’s data for clinical decision making.
Monitor different diagnostic tests and lab investigations if needed.
Implement interventions on patients and evaluate for the outcomes.
To conduct researches nurse can collect data.
To assess status of community and identify problems.
To detect changes in health care practices .
Administration of general and specific health survey.
Participation in early diagnosis and treatment
Identification and notification of certain specific diseases.
Health education.
5-Crude birth rate
Crude death rate
Infant mortality rate
Morbidity rate
Perinatal mortality rate
Maternal mortality rate
Life expectancy
General fertility rate
To understand:
The principles of detecting and controlling an
outbreak.
What is needed for outbreak investigation
Steps in disease outbreak investigations.
COUNTDOWN on WHO 2020 Targets: A Focus on helminthiasisCOUNTDOWN on NTDs
Professor Russell Stothard, COUNTDOWN's programme Director attended the Swiss Tropical and Public Health Institute's Winter symposium titled 'Helminth Infection - from Transmission to Control'
Presentation given at the launch of COUNTDOWN in CameroonCOUNTDOWN on NTDs
Providing an overview of progress and Neglected Tropical Diseases in Cameroon and highlighting future COUNTDOWN activities, this presentation was given at the launch in Cameroon.
A focus on NTDs in sub-Saharan Africa: Supporting scale-up of interventionsCOUNTDOWN on NTDs
Presentation at The Evidence and Organisations in Development Conference, at the University of Edinburgh’s Centre for Medical Anthropology and the Centre for African Studies.
Domestic Financing for Health in Africa: The Road of Sustainability and Owner...Linda Mtambo
Presentation delivered by Prof Alan Whiteside at the 17th ICASA Conference in Cape Town, South Africa as a panel participant on ‘The End of AIDS: Myth or reality?'
TB in the workplace and beyond - Contribution of Occupational Health Services...Jean Jacques Bernatas
The first part is a quick reminder of facts about TB that are necessary to go through part 2 and 3. Part 2 elaborate on how TB matters in OH, both as a hazardous place and as an opportunity to better screen, diagnose and treat workers. Win-win benefit for employers (TB has a huge cost for employers) and empoyees (to protect themselves, their families and communities). The conclusion will develop the concept of TB-proof workplace.
Transitioning from reaching every district to reaching every communityJSI
This presentation focuses on learning acquired from the last 2-3 year effort in 8 districts across both Uganda and Ethiopia and REC-QI potential to add to the arsenal of RI strengthening tools. REC is now the number one approach to reaching hard-to-reach health facilities. Adding Quality improvement to RED/REC will combine the “what” (RED/REC) and “how” (QI) factors to strengthening for sustainable improvement in coverage and brings together all EPI stakeholders. In addition, by working at both national and lower level, REC-QI encourages peer learning and incorporation of innovations into national policies, guidelines, and protocols.
El 12 de mayo de 2017 celebramos en la Fundación Ramó Areces una jornada con IS Global y Unitaid sobre enfermedades transmitidas por vectores, como la malaria, entre otras.
Survillance and notification of communicable diseasemubeenButt5
Ongoing, systematic collection, analysis and interpretation of health data.
Surveillance and notification of communicable disease
1-Closely integrated with the timely dissemination to those who need to know.
Application of the data to preventing and controlling disease.
2-Authoritative or urgent, formal or legal notice.
The action of notifying someone or something.
Something that gives official information to someone : the act of notifying someone.
3-Monitor closely to all patients.
Collect patient’s data for clinical decision making.
Monitor different diagnostic tests and lab investigations if needed.
Implement interventions on patients and evaluate for the outcomes.
To conduct researches nurse can collect data.
To assess status of community and identify problems.
To detect changes in health care practices .
Administration of general and specific health survey.
Participation in early diagnosis and treatment
Identification and notification of certain specific diseases.
Health education.
5-Crude birth rate
Crude death rate
Infant mortality rate
Morbidity rate
Perinatal mortality rate
Maternal mortality rate
Life expectancy
General fertility rate
To understand:
The principles of detecting and controlling an
outbreak.
What is needed for outbreak investigation
Steps in disease outbreak investigations.
COUNTDOWN on WHO 2020 Targets: A Focus on helminthiasisCOUNTDOWN on NTDs
Professor Russell Stothard, COUNTDOWN's programme Director attended the Swiss Tropical and Public Health Institute's Winter symposium titled 'Helminth Infection - from Transmission to Control'
Presentation given at the launch of COUNTDOWN in CameroonCOUNTDOWN on NTDs
Providing an overview of progress and Neglected Tropical Diseases in Cameroon and highlighting future COUNTDOWN activities, this presentation was given at the launch in Cameroon.
A focus on NTDs in sub-Saharan Africa: Supporting scale-up of interventionsCOUNTDOWN on NTDs
Presentation at The Evidence and Organisations in Development Conference, at the University of Edinburgh’s Centre for Medical Anthropology and the Centre for African Studies.
Domestic Financing for Health in Africa: The Road of Sustainability and Owner...Linda Mtambo
Presentation delivered by Prof Alan Whiteside at the 17th ICASA Conference in Cape Town, South Africa as a panel participant on ‘The End of AIDS: Myth or reality?'
TB in the workplace and beyond - Contribution of Occupational Health Services...Jean Jacques Bernatas
The first part is a quick reminder of facts about TB that are necessary to go through part 2 and 3. Part 2 elaborate on how TB matters in OH, both as a hazardous place and as an opportunity to better screen, diagnose and treat workers. Win-win benefit for employers (TB has a huge cost for employers) and empoyees (to protect themselves, their families and communities). The conclusion will develop the concept of TB-proof workplace.
Transitioning from reaching every district to reaching every communityJSI
This presentation focuses on learning acquired from the last 2-3 year effort in 8 districts across both Uganda and Ethiopia and REC-QI potential to add to the arsenal of RI strengthening tools. REC is now the number one approach to reaching hard-to-reach health facilities. Adding Quality improvement to RED/REC will combine the “what” (RED/REC) and “how” (QI) factors to strengthening for sustainable improvement in coverage and brings together all EPI stakeholders. In addition, by working at both national and lower level, REC-QI encourages peer learning and incorporation of innovations into national policies, guidelines, and protocols.
El 12 de mayo de 2017 celebramos en la Fundación Ramó Areces una jornada con IS Global y Unitaid sobre enfermedades transmitidas por vectores, como la malaria, entre otras.
Foot and Mouth Disease: Turkey recent developments in the region and outlooksFAO
Outlook achievement the WestEurasia Roadmap including
Recent Developments in the Region (Practical Epidemiology for Progressive Control (PepC))
Outlook gaps on the control of FMD in the Region (EARLY DETECTION / WELNET FMD)
Dr Nahit Yazıcıoğlu
President, Roadmap Advisory Group
Head of Animal Health and Quarantine Department
GDFC, MoFAL, TURKEY
Keynote address by Dr. Eric Goosby of UCSF, presented at CFAR HIV Research in International Settings (CHRIS) meeting in San Diego, October 1, 2014. Dr. Goosby discussed. "Global Health Delivery and Diplomacy: The Long Road to Sustainable Programs."
Towards Strengthening Equity and Inclusiveness in NTD approaches : Who is lef...COUNTDOWN on NTDs
Ms Christine Makia presented this during an Organised Session titled - Beyond 2020 with Neglected Tropical Diseases: Leaving no one behind in the journey 2030; during the European Congress on Tropical Medicine and International Health on 18th September 2019 in Liverpool.
Participatory research methods to improve community engagement and programme ...COUNTDOWN on NTDs
This presentation was given by Dr Luret Lar, Research Manager COUNTDOWN Nigeria during the European Congress on Tropical Medicine and International Health on 17th September 2019. This was during an organised session titled 'Health systems and Neglected Tropical Diseases a policy and practice debate: Inclusion, integration, innovation and implementation.' It was chaired by Dr Rachael Thomson, COUNTDOWN Director and higlights were presented by Dr Akinola Oluwole and Professor Sally Theobald.
‘Health system strengthening through integrated case management of neglected ...COUNTDOWN on NTDs
11th European Congress on Tropical Medicine and International Health presentation during the COUNTDOWN organised session titled: Health systems and Neglected Tropical Diseases a policy and practice debate: Inclusion, integration, innovation and implementation. It was presented on 17th September 2019.
The Changing Landscape of Communicating Science: Tips & Tricks for dismantlin...COUNTDOWN on NTDs
GIFs used in Slides 14 & 15, created by Global Health Strategies for #UHC2017
This presentation was given by Pamela Bongkiyung at the Science Communications International Society of Neglected Tropical Diseases (ISNTD) festival held on Tuesday, 27th March 2018; at the Wellcome Trust in London.
Professor Russell Stothard's presentation given to The Royal College of Pathologists on 6th March 2018 during the National Infection Study Day event. Prof Stothard focused on schistosomiasis and urogenital schistosomiasis pathology
Highlighting Water, Hygiene & Sanitation at the International Society for Neg...COUNTDOWN on NTDs
Dr Lucas Cunningham gave this presentation at the ISNTD WASH event on 23rd Nov. 2017. He collaborated in a workshop with other partners from SCI and GSA to further elaborate on WASH and its implications for NTDs.
Prof. Sally Theobald and Ms Laura Dean from COUNTDOWN gave a keynote at the International Federation of Anti-Leprosy Associations meeting on Wednesday, 18th October 2017.
Addressing Neglected Parasitic Diseases: Moving towards the development agend...COUNTDOWN on NTDs
This presentation was given by Prof David Molyneux at the British Society of Parasitology Autumn Symposium, held at the Linnean Society in London on 28th September 2017.
http://bsp.uk.net/2016/10/04/bsp-autumn-symposium-2017/
Interrupting Schistosomiasis Transmission: Taking sensible steps in Snail Con...COUNTDOWN on NTDs
This presentation was given by Prof. Russell Stothard, at the ISNTD Bites event that took place on Tuesday, 19th July 2017. It highlights the work being done in Cameroon to control Schistosomiasis transmission by reducing the snail population.
Epidemiological Analysis Workshop By Dr Suzanne Campbell COUNTDOWN on NTDs
This workshop was held in Yaounde, Cameroon on 24th March 2017 as part of the 'Towards Elimination of Schistosomiasis: A Paradigm Shift' Conference organised by Prof. Louis Albert Tchuem Tchuente, Director of the Centre for Schistosomiasis and Parasitology.
This presentation by Prof. Russell Stothard, COUNTDOWN's Director was given at the WHO NTD Summit on Friday, 21st April 2017. This session on Schistosomiasis was organised by the Global Alliance for Schistosomiasis (GSA).
Schistosomiasis towards 2030: From Global Expectations to local realitiesCOUNTDOWN on NTDs
This presentation was given by Prof. Russell Stothard, in his capacity as COUNTDOWN Director to the Global Center for Infectious Diseases (GCID) Symposium in Korea and to the Korean Society for Parasitology in mid-Feb. 2017
ISNTD WASH Conference - 1st November 2016 by Suzy CampbellCOUNTDOWN on NTDs
Water, Sanitation and Hygiene have been identified as a key component in efforts to fight Neglected Tropical Diseases. The Water conference provided an opportunity to explore the solutions WASH offers.
On the 28-30 September 2015 NTD Programme Managers met at a World Health Organization meeting. Our colleague Benjamin Marfo provided the update from Ghana.
Gender, Equity, Disability and Neglected Tropical DiseasesCOUNTDOWN on NTDs
This presentation was given my Margaret Gyapong at the Coalition for Operational Research on Neglected Tropical Diseases (NTDs) (COR-NTD) meeting in 2015. She raises critical questions about the links between gender, equity, disability and NTDs.
Presentation given by Laura Dean at the Royal Society conference The disease elimination agenda: the role of science, policy and advocacy http://rstmh.org/events/disease-elimination-agenda-role-science-policy-and-advocacy
Neglected tropical disease and co-infection: Female Genital Schistosomiasis i...COUNTDOWN on NTDs
Margaret Gyapong spoke at the 9th European Congress on Tropical Medicine and International Health in Basel Spetember 2015. This is her presentation on female genital schistosomiasis.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERYNEHA GUPTA
The process of drug discovery and development is a complex and multi-step endeavor aimed at bringing new pharmaceutical drugs to market. It begins with identifying and validating a biological target, such as a protein, gene, or RNA, that is associated with a disease. This step involves understanding the target's role in the disease and confirming that modulating it can have therapeutic effects. The next stage, hit identification, employs high-throughput screening (HTS) and other methods to find compounds that interact with the target. Computational techniques may also be used to identify potential hits from large compound libraries.
Following hit identification, the hits are optimized to improve their efficacy, selectivity, and pharmacokinetic properties, resulting in lead compounds. These leads undergo further refinement to enhance their potency, reduce toxicity, and improve drug-like characteristics, creating drug candidates suitable for preclinical testing. In the preclinical development phase, drug candidates are tested in vitro (in cell cultures) and in vivo (in animal models) to evaluate their safety, efficacy, pharmacokinetics, and pharmacodynamics. Toxicology studies are conducted to assess potential risks.
Before clinical trials can begin, an Investigational New Drug (IND) application must be submitted to regulatory authorities. This application includes data from preclinical studies and plans for clinical trials. Clinical development involves human trials in three phases: Phase I tests the drug's safety and dosage in a small group of healthy volunteers, Phase II assesses the drug's efficacy and side effects in a larger group of patients with the target disease, and Phase III confirms the drug's efficacy and monitors adverse reactions in a large population, often compared to existing treatments.
After successful clinical trials, a New Drug Application (NDA) is submitted to regulatory authorities for approval, including all data from preclinical and clinical studies, as well as proposed labeling and manufacturing information. Regulatory authorities then review the NDA to ensure the drug is safe, effective, and of high quality, potentially requiring additional studies. Finally, after a drug is approved and marketed, it undergoes post-marketing surveillance, which includes continuous monitoring for long-term safety and effectiveness, pharmacovigilance, and reporting of any adverse effects.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Top Effective Soaps for Fungal Skin Infections in India
COUNTDOWN on WHO 2020 Targets: A Focus on African Schistosomiasis
1. COUNTDOWN on WHO 2020 Targets:
A focus on African schistosomiasis
Russell Stothard
Department of Parasitology
E-mail: russell.stothard@lstmed.ac.uk
Twitter: @StothardRuss & @countdownonntds
2.
3. Background
Background on NTD control landscape
- from 2002 onwards to 2020 & 2030 perspectives
Focus on African schistosomiasis
- issues about surveillance, scale-up & control targets
Introducing COUNTDOWN implementation research
- why are multi-disciplinary approaches needed?
4. NTDs are strongly
associated with
poverty-stricken regions
within LMIC.
Broadly grouped into:
PC e.g. helminths
IDM e.g. protozoans
Control is largely by
partnerships typically
inspired by the London
Declaration in 2012.
WHO approved
strategies.
5. Several NTDs are amenable to preventive chemotherapy
• Preventive chemotherapy (PC) is a rapid
impact ‘health’ package (i.e. tool ready)
• Donated medicines, promoted access, often
with integrated drug administration(s)
• PC typically a ‘vertical-programme’ although
may use ‘horizontal-platforms’ at periphery
2020 challenges – scale-up, performance, impact, demand & sustainability
7. 694M
705M
711M
729M
700M
0
10
20
30
40
50
60
70
80
90
100
2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Target date for full PC scale-up
2020goals
WHO target of 75% coverage across diseases
%
Projected % of people receiving PC for at least one disease
(including LF, ONCH, SCH and STH) out of the total number that require PC
WHO’s scale-up of future PC to reach 2020 targets
Urgent need to
address bottlenecks in
scale-up of PC
and
to accelerate towards
WHO 2020 targets
The development of the NTD scorecard
9. 4th NTD scorecard shows un-even progress across diseases
Three reasons why schistosomiasis is placed in the RED?
First
PC is not a complete solution
Second
PC stretches health system performance
10. 4th NTD scorecard shows un-even progress across diseases
Three reasons why schistosomiasis is placed in the RED?
Third
Policies & practices are lagging behind technology, especially at micro-spatial
Infectious Diseases of Poverty
11. 4th NTD scorecard shows un-even progress across diseases
and more widely
the NTD implementation landscape is becoming more
dynamic (parasite/human/vector)
complex (mixed targets)
fragmented (communications)
and
fatigued (donors)
12. Reducing poverty in SSA with implementation science for NTD control
Programme of implementation research to inform the effective and sustainable scaling-
up of integrated Neglected Tropical Disease (NTD) control initiatives
OJEU: 2013/S 181-312697
Open tender: one final application for £8M in the Nov. 2014 - Oct. 2019 period
In 2008, DfID committed £50M for to support control of NTDs
Implementation portfolio including:
Sightsavers (Trachoma)
Schistosomiasis Control Initiative (ICOSA)
Centre for NTDs (LSTM)
UNITED (Nigeria)
….with The Research and Evidence Division supporting
13. COUNTDOWN
• Working in Liberia, Ghana, Nigeria & Cameroon
• Active research uptake/communications & 5 main research themes
14. Background
Background on NTD control landscape
- from 2002 onwards to 2030 perspectives
Focus on schistosomiasis & soil-transmitted helminthiasis
- issues about scale-up and accelerating towards targets
Introducing COUNTDOWN implementation research
- why are multi-disciplinary approaches needed?
15. 2030 Ensure healthy lives & promote well-being for all at all ages
How do NTDs fit in across this agenda?
both pro and con aspects
16. Mass Scale-up Theme 1:
Evidence Synthesis
Mass Scale-up Theme 2:
Applied Social Science
Mass Scale-up Theme 3:
Health Economics
Integrated Complementary Strategy Theme 1:
Macrofilaricides & Vector Control
Integrated Complementary Strategy 2:
Schistosomiasis/STH & Diagnostics
COUNTDOWN activities set across five major themes
17. Theobald (2017) et al.
• NTD interventions need better gender programming, reporting & analysis
But there are several current gaps
in gender & age-related equity
(maternal & child health - SCH)
18. • R F Burton FRGS
(1821-1890)
first cultural anthropologist
& cartographer of Africa
very likely had schistosomiasis
but still had a very colourful life
Multidisciplinary examples
19. Breaking across boundaries
is not easy and requires
• at individual-level
patience & respect
• at group-level
effective communications
but
• is very rewarding
holistic ‘team’ insight
• has broader appeal
pragmatic outcomes
20. Preventive chemotherapy needs intensification
How can NTD treatments
be scaled-up to meet the
demand?
What bottlenecks need to
be opened?
22. COUNTDOWN is a multi-country research consortium
COUNTDOWN
…generates research evidence to respond to
priority information needs of NTD policy makers
and program managers
…supports incorporation of evidence to
improve policies and operational plans and
practices for scale-up of NTD control
…strengthens capacity for evidence-based
decision making and planning through learning
by doing amongst its staff, associated partners
and country based research communities
reporting logframe of
impact, outcomes, outputs
meshed within a
theory of change
model and indicators
23. Mass Scale-up Theme 1:
Evidence Synthesis
Mass Scale-up Theme 2:
Applied Social Science
Mass Scale-up Theme 3:
Health Economics
Integrated Complementary Strategy Theme 1:
Macrofilaricides & Vector Control
Integrated Complementary Strategy 2:
Schistosomiasis/STH & Diagnostics
COUNTDOWN activities set across five major themes
‘ access / equity ’ of interventions
(better surveillance systems)
24. Background
Background on NTD control landscape
- from 2002 onwards to 2030 perspectives
Focus on schistosomiasis & soil-transmitted helminthiasis
- issues about scale-up and accelerating towards targets
Introducing COUNTDOWN implementation research
- why are multi-disciplinary approaches needed?
25. Peripatetic nature of tropical medicine studies
Parasitology
PZQ
Peri-urban areas of Ghana
Crater Lakes of Cameroon
exposure contamination
Mapping in Namibia
26. • Background
• Logistics
• Phase I & II
• Distribution
• Outlook
Mapping in Namibia – prior to COUNTDOWN
• Background
27. Background I
• Spatial distribution of schistosomiasis is focal
‘over-dispersion’ of prevalence (variance >> mean)
what ‘mapping data’ are needed for treatment decisions
‘under’ treatment
28. Background II
• What spatial resolution is needed to define the pattern?
sampling by: ecozone, administrative unit or sample ratio
granularity versus resolution
Unclear … clear … perfect?clear enough…
classic parasitology 1 : 20
with RDTs 1 : 4
(NOTE: towards exhaustive sampling)
29. Background II
• What spatial resolution is needed to define the pattern?
sampling by: ecozone, administrative unit or sample ratio
stability versus popularity ?
Unclear … clear … perfect?clear enough…
But political priorities change & so does
B&MGF and USAID priorities
30. Background III
• What spatial resolution is needed to define the pattern?
higher spatial resolution means more: time, money & samples
31. Logistics
• Namibia is in need of a background map for control
Stool & urine microscopy 1 : 20 (SCH & STH
urine RDTs & stool FOB
Phase I & II
Sample frame:
N=17 896 children from 299 schools
at each school 30 5-6 yo & 30 12-15 yo
Urine RDTs 1 : 4 (SCH – CCA & hemastix)
Questionnaire
History treatment
WASH
Symptomology
32. Logistics
• Pre-school children can be infected with schistosomiasis
- can they be monitored within school-based surveys too?
Ansong et al. (2011)
%ageprevalence
Typical age-prevalence relationship
Age and gender
5-6 yo 12-14 yo
%ageprevalence
Map distribution & flag a problem
10%+
Note: sample size per school doubles
this has both pro- and con- implications
33. Phase I & II • Mean SCH prevalence 9.0%
Phase I
Younger Older p-value
S. h. 7.1% 8.0% 0.19
S. m. 10.3% 11.9% 0.05*
Phase II
Younger Older
S. h. 3.4% 4.0% 0.09
S. m. 1.1% 0.9% 0.32
• Unusual age-prevalence
seasonal flooding (snails)
34. Distribution I
• SCH increased towards the East
Aggregating into treatments
WHO prevalence thresholds
0.0%
0.1-10.0%
10.1-50.0%
>50.0%
35. Distribution II
• Better estimate of PZQ needs through time
Aggregating into treatments
WHO prevalence thresholds
0.0%
0.1-10.0%
10.1-50.0%
>50.0%
36. • How much did this cost?
In total $126, 282 USD, roughly $7.06 per child
Outlook I
About 49% of costs were staff time (per diem)
For 1 : 4 resolution with RDTs
$3.59 USD per child
For 1 : 20 with microscopy
$9.55 USD
• Not forgetting the good GPS basemap of schools
• Could be cheaper without 5-6yo sampling?
37. Peripatetic nature of tropical medicine studies
Parasitology
PZQ
Peri-urban areas of Ghana
Crater Lakes of Cameroon
exposure contamination
39. 1) Precision mapping to
better tailor treatment
2) Mapping snail
distribution for control
3) Pinpointing key
water contact sites
Intensification of multisector actions for better impact
40. Research uptake:
targeted activities playing into policy action…
• Indicators of environmental transmission
- WASH factors, e-DNA tracers of NTDs
- PZQ MDA + biannual / expanded access
• Drivers of national policy change
- advocate for increased PZQ supplies
- accelerate towards public health goals
- widen health system engagement (NB academia)
44. Systematic review: FGS widespread but under-reported
COUNTDOWN implementation research
Also MGS in Malawi
45. 1. Gendered experiences of living in affected communities have often been
ignored in policies and interventions for schistosomiasis
2. Health workers lacked the capacity to effectively diagnosis and treat
female genital schistosomiasis (lack of awareness)
3. Qualitative studies have given voice to women and explored their broader
environment to assess ways to reduce transmission (revealed stigma)
4. New strategies and interventions are needed that reflect women and girls
lived experiences with this disease (encourage cross-sector dialogue)
5. Key intervention areas include:
bespoke training and educational interventions
gender sensitive WASH interventions
integration into gynaecological screening (HPV/cancers)
COUNTDOWN implementation research
In Ghana
47. Mass Scale-up Theme 1:
Evidence Synthesis
Mass Scale-up Theme 2:
Applied Social Science
Mass Scale-up Theme 3:
Health Economics
Integrated Complementary Strategy Theme 1:
Macrofilaricides & Vector Control
Integrated Complementary Strategy 2:
Schistosomiasis/STH & Diagnostics
COUNTDOWN activities set across five major themes
48. Conclusions (in three Cs)
Communicate (whatever language)
Cross-talk (break down silos)
Collaborate (teams reach targets)
49. Thank you Prof J. Cable & univ. of Cardiff
Key COUNTDOWN ICST-2 UK staff
Suzanne Campbell (LSTM)
Lucas Cunningham
Faye O’Halloran
Deborah Sankey
Tim Durant
Grace Macklin
Lisa O’Halloran
Zikmund Bartoníček
James LaCourse
Martyn Stewart
Emily Adams
Supporting the
COUNTDOWN
consortium
NHM David Rollinson Bonnie Webster
Tilburg Hospital Jaco Verweij
Lieden University Medical Centre Lisette van Leishout, Govert van Dam
Acknowledgements